Preview

Drug development & registration

Advanced search
Fullscreen

For citations:


Petrakov A.I., Sheikin V.V., Krivoshchekov S.V., Bezverkhniaia E.A., Guryev A.M., Belousov M.V. Development of the Tablet Dosage Form Composition for the Inductor of Hepatocytes Monooxygenase System Based on 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine. Drug development & registration. 2023;12(4):189-196. (In Russ.) https://doi.org/10.33380/2305-2066-2023-12-4-1517

Views PDF (Rus): 286


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)